Lung inflammation
[대역어] None
[용어속성] Symptom
[용어속성] Symptom
mRNA-1273 vaccination protects against SARS-CoV-2-elicited lung inflammation in nonhuman primates
mRNA-1273 백신 접종은 비인간 영장류에서 SARS-CoV-2 유발 폐 염증으로부터 보호합니다
Article
[키워드] 48 hour
48 hours
Antibody Response
Antibody responses
Antibody titer
Bronchoalveolar lavage fluid
CCL3
cellular
Cellular immune response
chemokines
collected
correlated
COVID-19
CXCL10
dissemination
dose-dependent manner
expression
Genes
Human
IFIT1
immune
immunology
immunology.
independent
induction
Inflammation
Inflammatory
ISG15
less
limit
Lower respiratory tract
lung
Lung inflammation
mRNA
mRNA-1273
MX1
observation
Pathogenesis
profile
PROTECT
replicated
respiratory tract
restrict viral replication
rhesus macaque
rhesus macaques
SARS-CoV-2
SARS-CoV-2 antibody response
SARS-CoV-2 antibody responses
SARS-CoV-2 spike
SARS-CoV-2 strain
serum
Support
suppressed
These data
transcriptomic
USA-WA1/2020
vaccination
Vaccine-induced immunity
variant of SARS-CoV-2
viral infection
viral replication
Viral RNA
[DOI] 10.1172/jci.insight.160039 PMC 바로가기 [Article Type] Article
[DOI] 10.1172/jci.insight.160039 PMC 바로가기 [Article Type] Article
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum
폴리(I:C) 플러스 명반과 관련된 SARS-CoV-2 삼량체 스파이크 단백질의 면역원성
Article
[키워드] addition
adjuvant
adjuvants
alum
antibody
B cell
BALF
Bronchoalveolar lavage fluid
CD4
CD8
Cellular immune response
Combination
domain
ELISA
enzyme
evaluated
expected
germinal centers
IgA
IgG
IgG anti-spike antibody
IgG1
IgG2a
immunization
immunogenicity
immunosorbent
in vitro
inactivated
induce
intradermal route
lung
Lung inflammation
mice
Neutralization assay
Neutralizing titer
neutralizing titers
neutrophil recruitment
New
Poly (I:C)
poly(I:C
positive
prefusion
produced
producing
Protein
RBD
reduced
reduction in
required
SARS-CoV-2
SARS-CoV-2 pandemic
SARS-CoV-2 virus
serum
spike
Spike protein
Subtypes
supported
T cell
Th1
Th1 phenotype
the SARS-CoV-2
trimeric
vaccination
Vaccination strategy
Vaccine
vaccine.
[DOI] 10.3389/fimmu.2022.884760 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.884760 PMC 바로가기 [Article Type] Article
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
Research
[키워드] acute respiratory syndrome
Administered
Beta
clinical development
controls
coronavirus
current
domain
dose
Express
expressing
hamster
hamsters
Human
IgA response
Immunity
immunization
immunized
immunogenic
intranasal
lack
Lineage
Lower respiratory tract
Lung inflammation
neutralized
pre-existing immunity
prefusion conformation
proline substitution
PROTECT
Protective
Protein
replicated
Replication
respiratory tract
response
S-2P
SARS-CoV-2
SARS-CoV-2 replication
SARS-CoV-2 S protein
SARS-CoV-2 spike protein
serum IgG
Serum neutralizing antibody
stability
stimulate
the S protein
the SARS-CoV-2
undetectable
upper respiratory tract
Vaccine
vaccine candidates
variants of concern
WA1/2020
weight loss
[DOI] 10.1038/s41541-022-00493-x [Article Type] Research
[DOI] 10.1038/s41541-022-00493-x [Article Type] Research
Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice
SARS-CoV-2에 감염된 마우스의 폐에서 염증의 사이토카인 및 지질 매개체
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Alanine
Analysis
analyzed
animal
animal model
animal models
Blood
blood clot
Blood clots
characterized
chemokine
chemokines
circulating
clinical manifestation
Concentration
coronavirus 2
coronavirus disease
coronavirus disease 19
correlated
COVID-19
Cytokines
D-dimer
D-dimers
different time point
different time points
elevated
ethanolamide
event
events
Features
Genes
glycerol
glycine
hallmark
highlight
histology
Human
hydroxy
indicated
Infection
Inflammation
inflammatory mediator
Inflammatory mediators
interferons
K18-ACE2
knowledge
leukocyte
leukocyte infiltration
Lipid
lipid mediator
lipid mediators of inflammation
lipids
lung
Lung inflammation
lung tissue
lung tissues
lung viral load
Lungs
mass spectrometry
Measures
mediator
mice
modulation
Other
Pathogenesis
pathogenesis.
pathology
pathophysiological
performed
PGF
plasma
Post-infection
produced
prostaglandin
reduced
Replication
RNA-seq analysis
robust
SARS-CoV-2
SARS-COV-2 infection
Severe acute respiratory syndrome
severe acute respiratory syndrome coronavirus 2
severe COVID-19
significantly
Support
Tandem mass spectrometry
therapeutic strategy
transcriptomic
transgenic mice
treat
uninfected
vasculature
viral replication
[DOI] 10.3389/fimmu.2022.893792 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.893792 PMC 바로가기 [Article Type] Article
Exploring the Role of Low-Density Neutrophils During Mycobacterium tuberculosis Infection
결핵균 감염 중 저밀도 호중구의 역할 탐색
Review
[키워드] addition
association
caused
centrifugation
COVID-19
disease
Disease progression
disease severity
driven by
elicit
expression
Frequency
highlight
highlighting
Host
immune response
increase in
infect
Infection
infections
Inflammation
inflammatory host response
low-density
low-density neutrophil
lung
Lung inflammation
marker
MDSC (myeloid-derived suppressor cell)
mounted
Mycobacterium tuberculosis
NDN
neutrophil
outcome
outcomes
pathology
recent
recent finding
recruitment
role
separated
severity
subpopulation
the disease
tissue damage
Tuberculosis
tuberculosis.
[DOI] 10.3389/fcimb.2022.901590 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fcimb.2022.901590 PMC 바로가기 [Article Type] Review
Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination
hACE2 마우스에서 SARS-CoV-2와 Streptococcus pneumoniae 간의 치명적인 시너지 효과와 예방 접종의 보호 효능
Article
[키워드] alveolar
approach
Bacteria
Bacterial
Bacterial infections
Combined
Complication
COVID-19
death
dose
effective
Efficacy
GM-CSF
hACE2
IFNs
immunology
incidence
Increased
Infection
Infectious disease
Influenza
lethal
lung
Lung inflammation
Macrophage
mice
Molecular pathology
mouse
Mouse models.
murine
occurred
pathogen
pathology
pneumococcal infection
pneumococci
Protective
reduced
respiratory infection
SARS-CoV-2
secondary
Streptococcus pneumoniae
subsequent
survival
synergistic
synergy
therapeutic targeting
Treatment
vaccination
viral respiratory infections
[DOI] 10.1172/jci.insight.159422 PMC 바로가기 [Article Type] Article
[DOI] 10.1172/jci.insight.159422 PMC 바로가기 [Article Type] Article
Inflammasome activation in infected macrophages drives COVID-19 pathology
감염된 대식세포의 인플라마좀 활성화는 COVID-19 병리를 유발합니다
Article
[키워드] ACE2 receptors
activate
Activation
antibody
attenuate
blockade
blocking
cascade
CD16
characterized
contributing to
COVID-19
COVID-19 pathology
Critical
disease
downstream
host infection
Human immune system
human macrophage
humanized
hyperinflammatory state
IFN
IL-1
IL-18
immune
in vivo
Infection
Infectious virus
Inflammasome
inflammasome activation
inflammasomes
Inflammatory cytokine
inflammatory cytokine production
inflammatory macrophages
Inflammatory response
interferon
Lung inflammation
Lung pathology
Lungs
Macrophage
macrophages
NLRP3 inflammasome
overactive
pathology
pathway
Prevent
pyroptosis
Remdesivir
Replication
required
SARS-CoV-2
SARS-COV-2 infection
Stage
sustained
undergo
viral replication
Viral RNA
[DOI] 10.1038/s41586-022-04802-1 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41586-022-04802-1 PMC 바로가기 [Article Type] Article
Lung targeted liposomes for treating ARDS
ARDS 치료를 위한 폐 표적 리포솜
Article
[키워드] accumulate
accumulation
acute respiratory distress
acute respiratory distress syndrome
Administered
administration
alveolar
approach
ARDS
BAL
Bronchoalveolar lavage
C57BL/6
characterized
combined treatment
COPD
COVID-19
COVID-19 infections
cysteine
cytokine secretion
distal
DPPC
drug
Efficiency
encapsulation
endotracheal
exhibited
Gas exchange
Hypoxemia
IL-1β
IL-6
impair
infections
Inflammation
Inflammatory marker
inflammatory markers
intravenous
intravenously
lipid composition
Lipid nanoparticles
lipopolysaccharide
Liposome
lung
lung damage
Lung diseases
lung disorders
lung endothelial
lung epithelial
Lung inflammation
Lungs
Macrophage
macrophages
marker
medication
Methylprednisolone
mice
mortality rate
mortality rates
MPS
mucolytic agent
Mucus
N-acetyl cysteine
NAC
nanoparticle
Nanotechnology
nitric oxide
outcome
Patient
penetration
provided
pulmonary
Pulmonary.
reached
reduce
reducing
Region
respiratory
respiratory distress
Respiratory distress syndrome
secretion
steroid
syndrome
therapeutic
therapeutic effect
therapeutic efficacy
TNFα
Treatment
Treatment outcome
were assessed
[DOI] 10.1016/j.jconrel.2022.03.028 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jconrel.2022.03.028 PMC 바로가기 [Article Type] Article
Salivary immunity of elite collegiate American football players infected with SARS-CoV-2 normalizes following isolation
Research
[키워드] AMPs
average
Biomarker
changes in
characterized
complex
Concentration
Control
COVID-19
COVID-19 infection
defensin
determine
Effect
General population
greater
groups
Human
Immunity
infected with SARS-CoV-2
Infection
Isolation
lactoferrin
LL-37
Lung inflammation
positive
Protein
remained
risk
salivary
SARS-CoV-2
secretion
t-test
tested
uninfected
were measured
were used
[DOI] 10.1038/s41598-022-12934-7 [Article Type] Research
[DOI] 10.1038/s41598-022-12934-7 [Article Type] Research